Dr. Robert Lowsky, MD
Claim this profileStanford University
Area of expertise
Immune Tolerance
Robert Lowsky, MD has run 3 trials for Immune Tolerance. Some of their research focus areas include:
Non-Hodgkin's Lymphoma
Robert Lowsky, MD has run 3 trials for Non-Hodgkin's Lymphoma. Some of their research focus areas include:
Affiliated Hospitals
Stanford University School Of Medicine
Stanford Multiple Sclerosis Center
Clinical Trials Robert Lowsky, MD is currently running
Axicabtagene Ciloleucel
for Non-Hodgkin Lymphoma
This is a phase Ib study to establish safety of Axi-Cel-2 in patients with Large B Cell Lymphoma (LBCL) who are at high risk of relapse.
Recruiting
1 award
Phase 1
Gene Therapy
for Sickle Cell Disease
This study is a first-in-human, single-arm, open-label Phase I/II study of nula-cel in approximately 15 participants, diagnosed with severe Sickle Cell Disease. The primary objective is to evaluate safety of the treatment in this patient population, as well as preliminary efficacy and pharmacodynamic data.
Recruiting
1 award
Phase 1 & 2
4 criteria
More about Robert Lowsky, MD
Clinical Trial Related
2 years of experience running clinical trials · Led 14 trials as a Principal Investigator · 3 Active Clinical Trials
Treatments Robert Lowsky, MD has experience with
- Cyclophosphamide
- Combined Deceased Donor Kidney And Hematopoietic Cell Transplants
- Conventional T Cells (Tcon) And Regulatory T Cells (Treg)
- Donor Stem Cells
- OrcaGraft (Orca-Q)
- GPH101 Drug Product
Breakdown of trials Robert Lowsky, MD has run
Immune Tolerance
Non-Hodgkin's Lymphoma
Acute Lymphoblastic Leukemia
Myelodysplastic Syndrome
Acute Myelogenous Leukemia
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Robert Lowsky, MD specialize in?
Robert Lowsky, MD focuses on Immune Tolerance and Non-Hodgkin's Lymphoma. In particular, much of their work with Immune Tolerance has involved HLA-A positive patients, or patients who are HLA-A negative.
Is Robert Lowsky, MD currently recruiting for clinical trials?
Yes, Robert Lowsky, MD is currently recruiting for 3 clinical trials in Palo Alto California. If you're interested in participating, you should apply.
Are there any treatments that Robert Lowsky, MD has studied deeply?
Yes, Robert Lowsky, MD has studied treatments such as Cyclophosphamide, Combined Deceased Donor Kidney and Hematopoietic Cell Transplants, Conventional T cells (Tcon) and Regulatory T cells (Treg).
What is the best way to schedule an appointment with Robert Lowsky, MD?
Apply for one of the trials that Robert Lowsky, MD is conducting.
What is the office address of Robert Lowsky, MD?
The office of Robert Lowsky, MD is located at: Stanford University, Palo Alto, California 94305 United States. This is the address for their practice at the Stanford University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.